Company intelligence
Orca Bio
Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.
About Orca Bio
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of blood cancer and autoimmune diseases. Our investigational products are designed to replace a patient’s diseased blood and immune system with a healthy one. Our manufacturing platform uses single-cell precision to create proprietary, uniquely-defined products that have the potential to revolutionize allogeneic cell therapy. Our team of leading scientists, engineers and clinicians is united in our mission to transform the lives of patients. Together, we are working to deliver the promise of a cure, without the compromise. Please note, a member of the Orca Bio team will only ever communicate using an @orcabio.com email address.
Verified activity
Signals from Orca Bio
4 published signals
Presence & Recognition
Orca Bio participated in WorldLeukemiaDay to raise awareness and recognize patients, families, caregivers, and communities impacted by leukemia.
Reported by Orca Bio
Presence & Recognition
Orca Bio spotlighted Kelly Terell, Orca Account Manager at Orca Bio, whose connection to the Blood Cancer Awareness Month mission is deeply personal.
Reported by Orca Bio
Presence & Recognition
Orca Bio is attending the fourteenth annual meeting of the Society of Hematology Oncology SOHO where it will present clinical data across its investigational high-precision cell therapy programs.
Reported by Orca Bio
Presence & Recognition
Orca Bio shared the story of Larry, an Orca Bio clinical trial participant living with MDS who received life-changing support from family and regular email updates.
Reported by Orca Bio